Skip to content

Effect of laparoscopic distal gastrectomy with preservation of the celiac branch of the vagus nerve

Effect of laparoscopic distal gastrectomy with preservation of the celiac branch of the vagus nerve - Preservation of celiac branch of vagus nerve

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000013652
Enrollment
60
Registered
2014-04-15
Start date
2014-04-15
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Early gastric cancer

Interventions

Laparoscopic distal gastrectomy with preservation of the celiac branch of the vagus nerve Laparoscopic distal gastrectomy without preservation of the celiac branch of the vagus nerve

Sponsors

Saitama Medical Center, Saitama Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) The indications for laparoscopic distal gastrectomy included the following: depth of tumor invasion limited to the mucosa or submucosa, absence of lymph node metastases in preoperative examinations, and a neoplasm of any histologic type. 2) PS 0-1 3) Inclusion criteria were as follows: a white blood cell count between 4000 and 8000 mm3; Hb level of over 10g/dl, a platelet count of over 10000 mm3, aspartate aminotransferase and alanine aminotransferase levels within 1.5 times the upper limit of normal for the institution; a serum bilirubin level of less than 1.5 mg dl; a serum creatinine level less than 1.2 mg/dl; BUN level less than 25 mg/dl; HbA1c level less than 6.

Exclusion criteria

Exclusion criteria: 1) Presence of cardiac dysfunction, liver and renal failure. 2) Presence of ascites 3) Unsatisfactory respiratory status 4) Presence of active infectious disease 5) Pregnancy 6) History of allergic reaction for drugs

Design outcomes

Primary

MeasureTime frame
Primary endpoint: gastrointestinal function after surgery

Secondary

MeasureTime frame
Secondary endpoint: Time to first appearance of defecation, volume of food intake, glucose tolerance (HbA1c)

Countries

Japan

Contacts

Public ContactErito Mochiki

Saitama Medical Center, Saitama Medical University Department of Digestive Tract and General Surgery

emochiki@saitama-med.ac.jp049-228-619

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026